Evolving Options for the Treatment of HCC With Immunotherapy and Liver Directed Therapy (LDT)

This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).

Evaluation for Credit: survey.alchemer.com/s3/7451259/9197-HCC-with-LDT-E…
CME/CE Information: www.francefoundation.com/9197-hcc-cme-enduring

This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).

This activity is supported by an educational grant from AstraZeneca.